July 2024

MORRISVILLE, NC., July 8, 2024 /PRNewswire/ — Immorna Biotherapeutics, Inc. (Immorna), a clinical stage biotechnology company developing both self-replicating and conventional mRNA-based therapeutics and vaccines, announced today that the U.S. Food and Drug Administration (FDA) has cleared its

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: